In the current study, we found that none of the circulating sF11R and ANXA5 could independently predictvascular function, which suggests that plasma levels of sF11R and ANXA5 may not be considered reliable indicators for the development and progression of vascular complications in T2DM. This evidence concerns the gene ANXA5 and type 2 diabetes mellitus.